GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / EpigenTek / EpiQuik Nuclear Extraction Kit II Nucleic Acid_Free / Product Detail : OP-0022-100 EpiQuik Nuclear Extraction Kit II Nucleic Acid_Free
#OP-0022-100 EpiQuik Nuclear Extraction Kit II Nucleic Acid_Free
Product name : EpiQuik Nuclear Extraction Kit II Nucleic Acid_Free
Catalog number : OP-0022-100
Quantity: 100 extractions
Supplier name : EpigenTek
Data sheet: Ask more or other datasheet now !
More Details about
OP-0022-100 EpiQuik Nuclear Extraction Kit II (Nucleic Acid-Free) (100 extractions)
The EpiQuik™ Nuclear Extraction Kit provides the simple and selective method for extracting nuclear proteins to be used for a variety of applications. These applications may include western blotting, protein-DNA binding assays, nuclear enzyme assays, and any other procedures requiring optimization or nucleic acidfree nuclear proteins. The EpiQuik™ Nuclear Extraction Kits are also specifically designed to meet the requirements of nuclear extracts used in various EpiQuik™ assays. The EpiQuik™ Nuclear Extraction Kits can be used to extract nuclear proteins from mammalian cells and tissue samples. The EpiQuik™ Nuclear Extraction Kits include kit I for regular nuclear extraction and kit II for nucleic acid-free nuclear extraction. The EpiQuik™ Nuclear Extraction Kit has the fastest procedure available on the current market, which can be completed within 60 minutes.
PRODUCT USE INFORMATION
The EpiQuik™ Nuclear Extraction Kit is very suitable for quick preparation of nuclear extracts from mammalian cells and tissue samples.
The EpiQuik™ Nuclear Extraction Kit is for research use only and is not intended for diagnostic or therapeutic application.
Epigentek guarantees the performance of all products in the manner described in
our product instructions.
Epigentek reserves the right to change or modify any product to enhance its
performance and design.
EpiQuik™ is a trademark of Epigentek Group Inc.
Components 100 extractions OP-0002-1
NE1 (10X pre-extraction buffer) 10 ml
NE2 (extraction buffer) 10 ml
1000X DTT solution 110 μl
1000X protease inhibitor cocktail (PIC) 110 μl
SHIPPING AND STORAGE
Store all components at 4°C. The kit is stable for up to 1 year from date of shipment when stored properly.
Cell Pellet Preparation
For Monolayer or Adherent Cells:
1. Grow cells to 70-80% confluence on a culture plate or flask (about 2-5 X 106 cells for a 100 mm plate). Remove the growth medium and wash cells with PBS twice and then remove PBS.
2. Add 1 ml of fresh PBS per 20 cm2 area (e.g., add 3 ml of PBS to a 100 mm plate), and scrape cells into a 15 ml conical tube. (Alternative option: detach cells with trypsin/EDTA and collect cells into a 15 ml conical tube. Count cells in a hemacytometer.)
3. Centrifuge the cells for 5 min at 1000 rpm and discard the supernatant.
4. Dilute NE1 with distilled water at a 1:10 ratio. Add DTT solution and PIC to ice cold diluted NE1 (1X) at a 1:1000 ratio. Re-suspend cell pellet in 100 μl of diluted NE1 per 106 cells and transfer to a micro centrifuge vial.
5. Incubate on ice for 10 min. Vortex vigorously for 10 sec and centrifuge the preparation for 1 min at 12,000 rpm.
6. Carefully remove the cytoplasmic extract from the nuclear pellet.
For Suspension Cells:
1. Grow cells to 2 X 106/ml and collect the cells into a 15 ml conical tube.
2. Centrifuge the cells for 5 min at 1000 rpm and discard the supernatant. Wash cells with PBS once by centrifugation for 5 min at 1000 rpm. Discard the supernatant.
3. Dilute NE1 with distilled water at a 1:10 ratio. Add DTT solution and PIC to ice cold diluted NE1 (1X) at a 1:1000 ratio. Re-suspend cell pellet in 100 μl of diluted NE1 per 106 cells and transfer to a micro centrifuge vial.
4. Incubate on ice for 10 min. Vortex vigorously for 10 sec and centrifuge
the preparation for 1 min at 12,000 rpm.
5. Carefully remove the cytoplasm extract from the nuclear pellet.
For Tissue Samples:
1. Weigh tissue and cut it into small pieces. Place cut pieces in a clean homogenizer. 2. Dilute NE1 with distilled water at a 1:10 ratio. Add 5 ml of diluted NE1 (1X) containing 5 μl of DTT per gram of tissue and homogenize tissue pieces (50-60 strokes).
3. Incubate on ice for 15 min and centrifuge for 10 min at 12,000 rpm at 4°C. Remove the supernatant.
Nuclear Extract Preparation
1. Add DTT solution and PIC to NE2 at a 1:1000 ratio. Add 2 volumes of NE2 containing DTT and PIC to nuclear pellet (about 10 μl per 106 cells or per 2 mg tissues). Incubate the extract on ice for 15 min with vortex (5 sec) every 3 min. The extract (especially tissue extract) can be further sonicated for 3 X 10 sec to increase nuclear protein extraction.
2. Centrifuge the suspension for 10 min at 14,000 rpm at 4°C and transfer the supernatant into a new microcentrifuge vial.
3. Measure the protein concentration of the nuclear extract.
4. Use immediately or aliquot and freeze the supernatant at –80°C until further use. Avoid freeze/thaw cycle.
Neri, F. et. al. (February 2012). Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells. Mol Cell Biol. 32(4):840-51. PubMed Abstract
Horiuchi A. et. al. (January 2012). Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation free hypoxia response element (HRE) of S100A4 gene. Int J Cancer. Epub ahead of print. PubMed Abstract
Galoian, K. et. al. (January 2012). mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops. Tumour Biol. Epub ahead of print. PubMed Abstract
Begum, G. et. al. (January 2012). Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J. Epub ahead of print. PubMed Abstract
Shu, L. et. al. (December 2011). Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells. AAPS J. 13(4):606-14. PubMed Abstract
Trisciuoglio, D. et. al. (November 2011). CPTH6, a thiazole-derivative, induces histone hypoacetylation and apoptosis in human leukemia cells. Clin Cancer Res. Epub ahead of print. PubMed Abstract
Yang, J. et. al. (November 2011). Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases. J Biol Chem. Epub ahead of print. PubMed Abstract
Huang, L. et. al. (August 2011). Prevention of transcriptional silencing by a replicator-binding complex consisting of SWI/SNF, MeCP1, and hnRNP C1/C2. Mol Cell Biol. 31(16):3472-84. PubMed Abstract
Cai, H. et. al. (August 2011). Inhibition of melanoma cell proliferation by targeting Wnt/ß-catenin pathway through Sox4 RNA interference. 31(4):656-9. PubMed Abstract
Yamawaki, Y. et. al. (August 2011). Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry. Epub ahead of print. PubMed Abstract
Geyer, K. et. al. (August 2011). Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni. Nat Commun. 2:424. PubMed Abstract
Fritzenwanger, M. et. al. (2011). Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells. Mediators Inflamm. 2011:429501. PubMed Abstract
Nandakumar, V. et. al. (April 2011). (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 32(4): 537-44. PubMed Abstract
Nocchi, L. et. al. (April 2011). Thrombomodulin Is Silenced in Malignant Mesothelioma by a Poly(ADP-ribose) Polymerase-1-mediated Epigenetic Mechanism. J Biol Chem. 286(22): 19478-88. Full PDF Article
Shi, Y. Y. et. al. (April 2011). Diet and Cell Size Both Affect Queen-Worker Differentiation through DNA Methylation in Honey Bees (Apis mellifera, Apidae). PLoS One. 6(4): e18808. PubMed Abstract
Jin, Y. et. al. (March 2011). Homocysteine levels impact directly on epigenetic reprogramming in astrocytes. Neurochem Int. Epub ahead of print. PubMed Abstract
Kawakami, K. et. al. (January 2011). Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Science. 102(1): 166-74. PubMed Abstract
Herrera, F. et. al. (December 2010). Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression. J Biol Chem. 285(50): 38915-22. Full PDF Article
Dusio, G. F. et. al. (November 2010). Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium. Immunol Cell Biol. Epub ahead of print. PubMed Abstract
Skowronski, K. et. al. (August 2010).Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics. 5(6):547-56. PubMed Abstract
Rugg-Gunn, PJ. et. al. (June 2010). Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo. Proc Natl Acad Sci USA. 107(24):10783-90. PubMed Abstract
Chen, F. et. al. (June 2010). Influence of silencing TRAF6 with shRNA on LPS/TLR4 signaling in vitro. Journal of Huazhong University of Science and Technology. 30(3): 278-84. PubMed Abstract
Pandey, M. et. al. (June 2010). Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. International Journal of Cancer. 126(11): 2520-33. PubMed Abstract
Hu, B. et. al. (May 2010). Epigenetic Regulation of Myofibroblast Differentiation by DNA Methylation. Am J Pathol. 177(1): 21-8. PubMed Abstract
Kawada, S. et. al. (May 2010). Increased oxygen tension attenuates acute ultraviolet-B-induced skin angiogenesis and wrinkle formation. Am J Physiol Regul Integr Comp Physiol. 299(2): R694-701. PubMed Abstract
Kastl, L. et. al. (April 2010). Effects of decitabine on the expression of selected endogenous control genes in human breast cancer cells. Mol Cell Probes. 24(2): 87-92. PubMed Abstract
Nishihara, M. et. al. (February 2010). Transcriptional regulation of the human establishment of cohesion 1 homolog 2 gene. Biochem Biophys Res Commun. 393(1): 111-7. PubMed Abstract
Perisic, T. et. al. (February 2010). Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology. 35(3): 792-805. PubMed Abstract
Duthie, S. J. et. al. (January 2010). Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev Res (Phila, Pa). 3(1): 92-100. PubMed Abstract
Majid, S. et. al. (January 2010). Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 116(1): 66-76. PubMed Abstract
Fritzenwanger, M. et. al. (2009). Cardiotrophin-1 induces tumor necrosis factor alpha synthesis in human peripheral blood mononuclear cells. Mediators Inflamm. 2009: 489802. PubMed Abstract
Fujishiro, H. et. al. (December 2009). Involvement of DNA hypermethylation in down-regulation of the zinc transporter ZIP8 in cadmium-resistant metallothionein-null cells. Toxicol Appl Pharmacol. 241(2): 195-201. PubMed Abstract
Watson, J. A. et. al. (October 2009). Generation of an epigenetic signature by chronic hypoxia in prostate cells. Human Molecular Genetics. 18(19): 3594-604. PubMed Abstract
Fujishiro, H. et. al. (August 2009). Involvement of DNA hypermethylation in down-regulation of the zinc transporter ZIP8 in cadmium-resistant metallothionein-null cells. Toxicology and Applied Pharmacology. 241(2): 195-201. PubMed Abstract
Zhang, X. Y. et. al. (June 2009). Promoter cloning and characterization of the rabbit BK channel beta1 subunit gene. Gene. 438(1-2): 33-9. PubMed Abstract
Nakamura, H. et. al. (May 2009). Role of angiotensin II type 1 receptor on retinal vascular leakage in a rat oxygen-induced retinopathy model. Ophthalmic Research. 41(4): 210-5. PubMed Abstract
Liu, Z. et. al. (May 2009). Modulation of DNA methylation by a sesquiterpene lactone parthenolide. Journal of Pharmacology and Experimental Therapeutics. 329(2): 505-14. PubMed Abstract
Majid, S. et. al. (April 2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 30(4): 662-70. PubMed Abstract
Wang, X. et. al. (January 2009). RAF may induce cell proliferation through hypermethylation of tumor suppressor gene promoter in gastric epithelial cells. Cancer Science. 100(1): 117-25. Full PDF Article
Fritzenwanger, M. et. al. (May 2008). Cardiotrophin-1 induces intercellular adhesion molecule-1 expression by nuclear factor ÎºB activation in human umbilical vein endothelial cells. Chin Med J. 121(24): 2592-2598. Full PDF Article
Roll, J. D. et. al. (January 2008). DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol. Cancer. 7: 15. Full PDF Article
Miyazaki, T. et. al. (October 2007). E-cadherin Gene Promoter Hypermethylation in H. pylori-Induced Enlarged Fold Gastritis. Helicobacter. 12(5): 523-531. PubMed Abstract
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1068: Nuclear Receptors
WP1099: Nuclear receptors in lipid metabolism and toxicity
WP1184: Nuclear Receptors
WP1326: Nuclear receptors in lipid metabolism and toxicity
WP1385: Nuclear Receptors
WP139: Nuclear receptors in lipid metabolism and toxicity
WP1502: Mitochondrial biogenesis
WP170: Nuclear Receptors
WP1845: MAPK targets/ Nuclear events mediated by MAP kinases
WP217: Nuclear Receptors
WP299: Nuclear receptors in lipid metabolism and toxicity
WP431: Nuclear receptors in lipid metabolism and toxicity
WP509: Nuclear Receptors
WP755: Nuclear receptors in lipid metabolism and toxicity
WP831: Nuclear Receptors
WP863: Nuclear receptors in lipid metabolism and toxicity
WP950: Nuclear Receptors
WP981: Nuclear receptors in lipid metabolism and toxicity
Related Genes :
 Aberrant histone methylation in the patients with immune thrombocytopenia.
 Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis.
 Aberrant histone acetylation and methylation levels in woman with endometriosis.
 Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris.
 Abnormal histone modification patterns in lupus CD4+ T cells.
Enter catalog number :